Home
|Insights
|“Pharmaceutical legislation & regulatory developments,” and “The case of Dimethyl Fumarate: where is it heading to?,” 19th Legal Affairs Conference, Medicines for Europe, Brussels

PDF Link

“Pharmaceutical legislation & regulatory developments,” and “The case of Dimethyl Fumarate: where is it heading to?,” 19th Legal Affairs Conference, Medicines for Europe, Brussels

Speaking Engagement | 06.23.25

Contacts

Kristof Roox
Partner
- Brussels
  - D | +32.2.282.1843
a3Jvb3hAY3Jvd2VsbC5jb20=

Insights

Speaking Engagement | 12.11.25

"Ounce of Prevention Session (OOPS) Navigating the Current Compliance, Enforcement, and Oversight Landscape," NAPABA 2025

Speaking Engagement | 12.11.25
"The State of AI Regulation", New York Technology Innovation 2025
Speaking Engagement | 12.10.25
"Antitrust Basics, Updates, and Insights – Navigating Antitrust Issues in Healthcare Markets," Crowell & Moring Webinar.
Speaking Engagement | 12.05.25
"Key Takeaways From DOJ's Civil Cyber-Fraud Initiative," ABA Cyber Meeting

View All Insights

Subscribe

to the latest insights from our team